Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
about
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionCorticosteroids or ACTH for acute exacerbations in multiple sclerosis.Drug therapy for multiple sclerosis.How do corticosteroids influence myelin genesis in the central nervous system?A predictive model for corticosteroid response in individual patients with MS relapsesQuantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology.Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013.How to run a multiple sclerosis relapse clinic.Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome.Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospitalGlucocorticoids increase skeletal muscle NF-κB inducing kinase (NIK): links to muscle atrophy.Identifying the cellular targets of drug action in the central nervous system following corticosteroid therapy.Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasoneEfficacy of orally administered prednisolone versus partial endodontic treatment on pain reduction in emergency care of acute irreversible pulpitis of mandibular molars: study protocol for a randomized controlled trial.Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.Outcome of MS relapses in the era of disease-modifying therapy.Corticosteroids in the management of acute multiple sclerosis exacerbations.An Accident-Prone Employee: No, Multiple Sclerosis.Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?
P2860
Q26822611-0E82BB0B-573F-4C06-AA96-354CB4D3B8EAQ33921755-652CA048-F9A1-4AFA-B845-4CF1E0A92301Q33990246-755A2A0F-18E7-4881-862F-60EB665F0899Q34095959-B3681196-1DE2-4C70-BE19-481AED62B28BQ35192482-29D3E49E-2A6A-4723-9776-01DAC4E3BA51Q35811145-F7D36DF9-EEB0-45AC-87E8-821DDE633E2BQ35903495-CDCD6278-2D4B-4D60-923D-48738A64CA3FQ36088282-3FEE5CA2-6F42-4AF5-B69F-DF32E8529B1DQ36577187-73B19C3A-9B2E-43E8-A786-1AFA45F78E76Q36727762-22E1B0AD-F614-4DF5-8F8B-40BFD85A9F0EQ36816593-00C84012-BDB4-4BD6-9CED-9AEF7957C16BQ36917767-CA75B25F-46E7-4BAC-B812-D20ABA656F60Q37419006-4205D40D-F590-4129-A42E-FDFAFBDB476AQ37489879-5A47AF3C-180E-44C7-BA08-CF0C2A1CF038Q37628186-87C93993-A7C0-48AF-98CE-B0800A33C4B4Q37727028-64729B95-321E-47B6-93DE-1A9FBFD9A960Q38137114-F0F40D6D-4CBD-4C1D-9B0F-DAEA14C0CCF4Q38636590-E3E48AF0-D8EA-4F02-B6EB-22CCC7B4609DQ39229363-17D54D44-D878-4214-81B9-FC3B3AE4B7B9Q46129836-AE6E5237-5515-4EEE-A823-879A56DF2953Q47158177-85A696FD-1F70-49BE-A331-F2A2A42CD200Q48290435-35C0DEC5-F62F-43B5-9F4A-50BBAE0912C5
P2860
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@ast
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en-gb
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@nl
type
label
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@ast
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en-gb
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@nl
prefLabel
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@ast
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en-gb
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@nl
P2093
P2860
P1476
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
@en
P2093
Jodie M Burton
Marika Hohol
Paul W O'Connor
P2860
P304
P356
10.1002/14651858.CD006921.PUB3
P407
P577
2012-12-12T00:00:00Z